Autologous CD34+ selected bone marrow cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CD34+ selected bone marrow cells, covering 2013-11-18 to 2013-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction [Phase 1]